ArticleFrontiers in cardiovascular medicine2025
The kinetics of CA125 levels as a prognostic marker for in-hospital mortality in patients with acute heart failure: a pilot study.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Evaluation of technical and economic outcomes of contact force-sensing catheters for pulmonary vein isolation in symptomatic paroxysmal atrial fibrillation in a developing country.Indian pacing and electrophysiology journalArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Acute heart failure (AHF) carries a high risk of in-hospital mortality, and identifying reliable prognostic biomarkers remains challenging. Cancer antigen 125 (CA125) has recently emerged as a potential marker in heart failure, but its prognostic value for in-hospital mortality in AHF is unclear. This pilot study examined the kinetics of CA125 and its association with in-hospital mortality in AHF patients. Methods: In this single-center prospective cohort study, 80 participants were enrolled and divided into three groups: AHF ( Results: CA125 levels were significantly higher in the AHF group (median 127.5 U/ml) compared to the CHF (15.8 U/ml, Conclusion: CA125 levels are higher in AHF patients than in CHF patients and controls. An increase in CA125 after 7 days of treatment compared with admission levels is linked to higher in-hospital mortality. Larger multicenter studies are needed to confirm the role of CA125 in heart failure management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.